The impact of body composition on short-term outcomes of neoadjuvant chemotherapy with gemcitabine plus S-1 in patients with resectable pancreatic cancer

ConclusionsIn our experience, NAC GS was similarly tolerable and effective in resectable pancreatic cancer patients regardless of the presence of sarcopenia.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research